Chalk up yet another success for adult stem cell therapy!
According to the UK Telegraph, researchers in Britain have taken stem cells from a patient’s own body fat to stimulate the regrowth of tissue damaged by multiple sclerosis.
Last year experts suggested that stem cell therapy could be a “cure” for MS within the next 15 years.
Patients’ symptoms were still improving up to a year after the treatment, the new study shows.
One, a 50-year-old man, who had suffered more than 600 painful seizures in the three years before treatment has not had a single one since the infusion of his own cells.
Another patient’s ability to walk, run and even cycle are still improving 10 months after the therapy.
Apparently there are a couple of studies underway, and the second one is also reporting excellent results:
Earlier this year another study in 21 patients injected with their own bone marrow stem cells, found that 81 per cent saw significant improvements to their disability.
The successful treatments derived from adult stem cell therapy is somewhere between 70 and 80; there has yet to be one reported successful therapy from embryonic stem cell research, despite years of trying in the United States and internationally, with both private funding and taxpayer funding.
While adult stem cell therapy uses a patent’s own stem cells gathered from places such as fat tissue, nasal tissue, dental tissue, testicles and more, embronic stem cell research destroys a human embryo during the harvesting process. Embryonic Stem Cell (ESC) research also has problems with tissue rejection (as seen with organ transplants) and the generation of tumors in the recipient, as seen in an unfortunate Israeli boy who received fetal stem cell therapy.
Science is continually proving that not only is the moral high ground better ethically, it is also more successful than methods that sacrifice innocent human life in the process.